At the completion of this activity, the participant will be able to:
1.  Review hyperlipidemia pathophysiology, lab values, and indications for treatment
2.  Identify goals of therapy, including guideline updates to cholesterol goal levels, based on patient risk factors
3.  Describe non-statin hyperlipidemia therapies, including mechanisms of action, indications for use, efficacy, and side effects
4.  Explain treatment algorithms to guide clinical decision making